$PLYX SEC Filings

Filed On	Filing
14 Sep 2026	8-K: Submission of Matters to a Vote of Security Holders Polaryx Therapeutics, Inc. (the “Company”), held its Annual Meeting of Stockholders on Thursday, September 10, 2026. For more information on the following proposals, refer to the Company’s Proxy Statement filed with the Securities and Ex...
01 Sep 2026	8-K: Regulation FD Disclosure; Other Events
13 Aug 2026	QUARTERLY REPORT
28 Jul 2026	ARS
28 Jul 2026	DEFINITIVE ADDITIONAL MATERIALS
28 Jul 2026	Proxy statement: annual meeting on September 10, 2026
24 Jul 2026	REGISTRATION STATEMENT
21 Jul 2026	8-K: Departure/Election of Directors or Officers; Compensation
17 Jul 2026	8-K: Shareholder Director Nominations; Other Events
28 May 2026	Form 4: Yang Alex Keun Mo, Director and 1 other Bought 88,453 shares ($360K)
28 May 2026	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +1 more
15 May 2026	QUARTERLY REPORT
24 Mar 2026	ANNUAL REPORT
20 Feb 2026	Form 4: Landis G. Michael, Director Bought 2,867 shares ($7.99K)
05 Feb 2026	SCHEDULE 13D
02 Feb 2026	PROSPECTUS
29 Jan 2026	EFFECT
29 Jan 2026	Form 3: Yang Alex Keun Mo, Director and 1 other Holds 1,400,000 shares of Common Stock
29 Jan 2026	Form 3: Braun Iii Francis A, Director No securities owned
29 Jan 2026	Form 3: Bollinger Lisa, Chief Medical Officer Holds 150,358 shares of Common Stock

Comments